WCA
IDXX icon

Waratah Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Waratah Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,400
Closed -$1.01M – 194
2025
Q1 		$1.01M Buy
+2,400
New +$1.04M 0.03% 147

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Waratah Capital Advisors's IDXX Position: Q1 2026 in Review

Waratah Capital Advisors reduced its Idexx Laboratories (IDXX) stake by 31% in Q1 2026, selling an estimated $203K and leaving 718 shares worth $403K. The position accounts for 0.02% of the portfolio, ranked #123.

Waratah Capital Advisors first reported a position in IDXX in Q1 2018 and has held it in 20 quarters since. The position peaked at $51.8M in Q1 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Waratah Capital Advisors held 718 shares of Idexx Laboratories worth $403K as of Q1 2026.
  • Waratah Capital Advisors sold 316 Idexx Laboratories shares in Q1 2026, an estimated $203K.
  • Idexx Laboratories made up 0.02% of Waratah Capital Advisors's portfolio in Q1 2026, its #123 holding.
  • Waratah Capital Advisors first reported a position in Idexx Laboratories in Q1 2018 and has held it in 20 quarters since.
  • Waratah Capital Advisors's Idexx Laboratories position peaked at $51.8M in Q1 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Waratah Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.